Altimmune, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $3.2M | $2.7M |
| FY2010 | — | $12.2M | $11.8M |
| FY2011 | — | $15.9M | $11.2M |
| FY2012 | $1.7M | $11.7M | $12.7M |
| FY2013 | $730.3K | $7.3M | $10.5M |
| FY2014 | — | $18.3M | $18.6M |
| FY2015 | — | $43.1M | $15.6M |
| FY2016 | — | $32.2M | $2.9M |
| FY2017 | $599.9K | $39.4M | $8.8M |
| FY2018 | $1.9M | $48.3M | $33.7M |
| FY2019 | $1.9M | $45.5M | $9.0M |
| FY2020 | $1.8M | $225.9M | $115.9M |
| FY2021 | $1.5M | $199.1M | $190.3M |
| FY2022 | $4.6M | $185.3M | $111.1M |
| FY2023 | — | $194.1M | $135.1M |
| FY2024 | — | $123.5M | $36.9M |
| FY2025 | $34.3M | $224.9M | $43.8M |